MedPath

Wellstat Therapeutics Corp.

Wellstat Therapeutics Corp. logo
🇺🇸United States
Ownership
Private
Employees
51
Market Cap
-
Website
http://www.wellstattherapeutics.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

FDA:2

Drug Approvals

XURIDEN

Approval Date
Nov 11, 2022
FDA

VISTOGARD

Approval Date
Nov 15, 2018
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.